AXLA / Axcella Health Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Axcella Health Inc.
US ˙ OTCPK ˙ US05454B1052
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier1.125.152 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Axcella Health Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i AXLA / Axcella Health Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-10-13 Societe des Produits Nestle S.A. 3.658.536 1,6400 146.341 41,0000 5.999.999 1 44.75 548.761 9,15
2022-10-13 Flagship Ventures Fund IV General Partner LLC 2.743.902 1,6400 109.756 41,0000 4.499.999
2022-10-13 Flagship Ventures Fund IV General Partner LLC 2.757.333 1,6400 110.293 41,0000 4.522.026
2022-10-13 Flagship Ventures Fund IV General Partner LLC 914.634 1,6400 36.585 41,0000 1.500.000
2022-10-13 Flagship Ventures Fund IV General Partner LLC 919.111 1,6400 36.764 41,0000 1.507.342
2022-10-13 Flagship Ventures Fund IV General Partner LLC 3.048.780 1,6400 121.951 41,0000 4.999.999
2022-03-16 Flagship Ventures Fund IV General Partner LLC 3.791.623 1,9100 151.665 47,7500 7.242.000
2022-03-16 Flagship Ventures Fund IV General Partner LLC 947.905 1,9100 37.916 47,7500 1.810.499
2022-03-16 Flagship Ventures Fund IV General Partner LLC 1.579.843 1,9100 63.194 47,7500 3.017.500

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AXLA / Axcella Health Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i AXLA / Axcella Health Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-10-19 Hinshaw William 16.000 1,5642 640 39,1050 25.027 77 0.3057 -24.831 -99,22
2022-09-06 Koziel Margaret 547 2,5195 22 62,9875 1.378
2022-06-01 Koziel Margaret 590 2,0107 24 50,2675 1.186
2022-03-01 Koziel Margaret 553 1,8618 22 46,5450 1.030
2022-01-31 Hinshaw William 16.590 1,6512 664 41,2800 27.393
2021-02-01 Chakravarthy Manu 18.472 5,5019 739 137,5475 101.631

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

AXLA / Axcella Health Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2023-03-03 2023-03-01 4 Koziel Margaret AXLA Common Stock S - Sale D 0,5800 -679 -0 24.883
2023-02-13 2023-02-10 4 Fehlner Paul AXLA Common Stock S - Sale D 0,6602 5.221 3 58.081
2022-10-19 2022-10-19 4 Hinshaw William AXLA Common Stock S - Sale D 1,5642 -16.000 -25 82.012
2022-10-19 2022-10-17 4 Hinshaw William AXLA Common Stock A - Award D 50.000 98.012
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By FPA, L.P. AXLA Common Stock P - Purchase I 1,6400 3.048.780 5.000 3.048.780
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Opportunities I, L.P. AXLA Common Stock P - Purchase I 1,6400 919.111 1.507 6.299.611
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Opportunities I, L.P. AXLA Common Stock P - Purchase I 1,6400 914.634 1.500 5.380.500
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV, L.P. AXLA Common Stock P - Purchase I 1,6400 2.757.333 4.522 14.101.638
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV, L.P. AXLA Common Stock P - Purchase I 1,6400 2.743.902 4.500 11.344.305
2022-10-17 3 FPA, L.P. By FPA, L.P. AXLA Common Stock I 3.048.780
2022-10-17 2022-10-13 4 Societe des Produits Nestle S.A. AXLA Common Stock P - Purchase I 1,6400 3.658.536 6.000 11.105.438
2022-09-08 2022-09-06 4 Koziel Margaret AXLA Common Stock S - Sale D 2,5195 -547 -1 25.562
2022-06-03 2022-05-19 4 Epstein David R AXLA Common Stock A - Award D 47.059 209.756
2022-06-02 2022-06-01 4 Koziel Margaret AXLA Common Stock S - Sale D 2,0107 -590 -1 26.109
2022-05-25 2022-05-19 4 SEKHRI PAUL J AXLA Stock Option (Right to Buy) A - Award D 1,70 40.000 40.000
2022-05-23 2022-05-19 4 Hendrix Martin AXLA Stock Option (Right to Buy) A - Award D 1,70 40.000 40.000
2022-05-23 2022-05-19 4 Sohn Catherine A. AXLA Stock Option (Right to Buy) A - Award D 1,70 20.000 20.000
2022-05-23 2022-05-19 4 Baird William D III AXLA Stock Option (Right to Buy) A - Award D 1,70 20.000 20.000
2022-05-23 2022-05-19 4 Pisano Gary P. AXLA Stock Option (Right to Buy) A - Award D 1,70 20.000 20.000
2022-05-23 2022-05-19 4 Rondinone CRISTINA AXLA Stock Option (Right to Buy) A - Award D 1,70 20.000 20.000
2022-05-23 3 Rosenblatt Michael AXLA Common Stock D 3.053
2022-05-23 2022-05-19 4 Rosenblatt Michael AXLA Stock Option (Right to Buy) A - Award D 1,70 40.000 40.000
2022-03-21 2022-03-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.535 0
2022-03-21 2022-03-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.535 162.697
2022-03-21 2022-03-17 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 2,51 50.000 50.000
2022-03-18 2022-03-16 4 Crane Robert AXLA Stock Option (Right to Buy) A - Award D 1,63 125.000 125.000
2022-03-18 2022-03-16 4 Hinshaw William AXLA Common Stock P - Purchase D 1,9100 13.089 25 48.012
2022-03-18 2022-03-16 4 Crane Robert AXLA Common Stock P - Purchase D 1,9100 39.267 75 39.267
2022-03-18 2022-03-16 4 Epstein David R AXLA Common Stock P - Purchase D 1,9100 26.178 50 161.162
2022-03-18 2022-03-16 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Opportunities I, L.P. AXLA Common Stock P - Purchase I 1,9100 1.579.843 3.018 4.465.866
2022-03-18 2022-03-16 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV-Rx, L.P. AXLA Common Stock P - Purchase I 1,9100 947.905 1.810 2.004.657
2022-03-18 2022-03-16 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV, L.P. AXLA Common Stock P - Purchase I 1,9100 3.791.623 7.242 8.600.403
2022-03-18 2022-03-16 4 Fehlner Paul AXLA Common Stock P - Purchase D 1,9100 10.471 20 20.802
2022-03-16 2022-03-16 4 Societe des Produits Nestle S.A. AXLA Common Stock P - Purchase I 1,9100 3.141.361 6.000 7.446.902
2022-03-03 2022-03-01 4 Koziel Margaret AXLA Common Stock S - Sale D 1,8618 -553 -1 26.699
2022-02-23 2022-02-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.534 1.535
2022-02-23 2022-02-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.534 134.984
2022-02-10 2022-02-08 4 Schecter Alison D. AXLA Stock Option (Right to Buy) A - Award D 1,63 56.000 56.000
2022-02-10 2022-02-08 4 Fehlner Paul AXLA Stock Option (Right to Buy) A - Award D 1,63 70.000 70.000
2022-02-10 2022-02-08 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 5,00 100.000 100.000
2022-02-10 2022-02-08 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 1,63 275.000 275.000
2022-02-10 2022-02-08 4 Koziel Margaret AXLA Stock Option (Right to Buy) A - Award D 1,63 33.397 33.397
2022-02-10 2022-02-08 4 Dean Virginia R AXLA Stock Option (Right to Buy) A - Award D 1,63 71.400 71.400
2022-02-01 2022-01-31 4 Hinshaw William AXLA Common Stock S - Sale D 1,6512 -16.590 -27 33.410
2022-02-01 2022-01-28 4 Hinshaw William AXLA Restricted Stock Units M - Exercise D -50.000 0
2022-02-01 2022-01-28 4 Hinshaw William AXLA Common Stock M - Exercise D 50.000 50.000
2022-01-20 2022-01-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.535 3.069
2022-01-20 2022-01-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.535 133.450
2021-12-20 2021-12-17 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.535 4.604
2021-12-20 2021-12-17 4 Epstein David R AXLA Common Stock M - Exercise D 1.535 131.915
2021-12-14 2021-12-10 4 Schecter Alison D. AXLA Stock Option (Right to Buy) A - Award D 5,57 25.000 25.000
2021-12-13 3 Koziel Margaret AXLA Common Stock D 30.000
2021-12-13 2021-12-10 4 Koziel Margaret AXLA Stock Option (Right to Buy) A - Award D 2,60 75.000 75.000
2021-11-22 2021-11-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.534 6.139
2021-11-22 2021-11-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.534 130.380
2021-10-19 2021-10-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.535 7.673
2021-10-19 2021-10-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.535 128.846
2021-09-20 2021-09-17 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.535 9.208
2021-09-20 2021-09-17 4 Epstein David R AXLA Common Stock M - Exercise D 1.535 127.311
2021-08-25 2021-08-13 4 Pisano Gary P. AXLA Stock Option (Right to Buy) M - Exercise D 0,28 -81.433 0
2021-08-25 2021-08-13 4 Pisano Gary P. AXLA Common Stock M - Exercise D 0,2800 81.433 23 81.433
2021-08-19 2021-08-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.534 10.743
2021-08-19 2021-08-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.534 125.776
2021-07-20 2021-07-16 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.535 12.277
2021-07-20 2021-07-16 4 Epstein David R AXLA Common Stock M - Exercise D 1.535 124.242
2021-06-25 2021-06-22 4 Dean Virginia R AXLA Stock Option (Right to Buy) A - Award D 4,15 140.000 140.000
2021-06-21 2021-06-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.535 13.812
2021-06-21 2021-06-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.535 122.707
2021-05-24 2021-05-20 4 Baird William D III AXLA Stock Option (Right to Buy) A - Award D 3,24 20.000 20.000
2021-05-24 2021-05-20 4 Rondinone CRISTINA AXLA Stock Option (Right to Buy) A - Award D 3,24 20.000 20.000
2021-05-24 2021-05-20 4 Sohn Catherine A. AXLA Stock Option (Right to Buy) A - Award D 3,24 20.000 20.000
2021-05-24 2021-05-20 4 Aradhye Shreeram AXLA Stock Option (Right to Buy) A - Award D 3,24 20.000 20.000
2021-05-24 2021-05-20 4 Behar Gregory AXLA Stock Option (Right to Buy) A - Award D 3,24 20.000 20.000
2021-05-24 2021-05-20 4 Hoge Stephen AXLA Stock Option (Right to Buy) A - Award D 3,24 20.000 20.000
2021-05-24 2021-05-20 4 Pisano Gary P. AXLA Stock Option (Right to Buy) A - Award D 3,24 20.000 20.000
2021-05-20 2021-05-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.534 15.347
2021-05-20 2021-05-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.534 121.172
2021-04-20 2021-04-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1.535 16.881
2021-04-20 2021-04-18 4 Epstein David R AXLA Common Stock M - Exercise D 1.535 119.638
2021-03-22 2021-03-18 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 5,43 120.000 120.000
2021-03-22 2021-03-18 4 Epstein David R AXLA Restricted Stock Units A - Award D 18.416 18.416
2021-03-18 2021-03-17 4 Schecter Alison D. AXLA Stock Option (Right to Buy) A - Award D 5,57 250.000 250.000
2021-02-11 2021-02-09 4 Chardonnet Laurent AXLA Stock Option (Right to Buy) A - Award D 3,40 25.000 25.000
2021-02-11 2021-02-09 4 Chardonnet Laurent AXLA Stock Option (Right to Buy) A - Award D 6,59 120.000 120.000
2021-02-11 2021-02-09 4 Chardonnet Laurent AXLA Restricted Stock Units A - Award D 60.000 60.000
2021-02-11 2020-10-30 4 Chardonnet Laurent AXLA Common Stock A - Award D 3,6000 2.601 9 6.266
2021-02-11 2021-02-09 4 Fehlner Paul AXLA Stock Option (Right to Buy) A - Award D 6,59 85.000 85.000
2021-02-11 2021-02-09 4 Fehlner Paul AXLA Restricted Stock Units A - Award D 42.500 42.500
2021-02-11 2021-02-09 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 6,59 375.000 375.000
2021-02-11 2021-02-09 4 Chakravarthy Manu AXLA Stock Option (Right to Buy) A - Award D 6,59 102.000 102.000
2021-02-03 2021-02-01 4 Chakravarthy Manu AXLA Restricted Stock Units M - Exercise D 60.000 60.000
2021-02-03 2021-02-01 4 Chakravarthy Manu AXLA Common Stock S - Sale D 5,5019 -18.472 -102 41.528
2021-02-03 2021-02-01 4 Chakravarthy Manu AXLA Common Stock M - Exercise D 60.000 60.000
2021-02-03 2020-08-01 4 Chakravarthy Manu AXLA Restricted Stock Units A - Award D 60.000 60.000
2020-10-01 2020-09-29 4 Hinshaw William AXLA Restricted Stock Units A - Award D 50.000 50.000
2020-09-18 2020-09-16 4 Fehlner Paul AXLA Stock Option (Right to Buy) A - Award D 4,72 30.000 30.000
2020-09-09 2020-09-08 4 Societe des Produits Nestle S.A. AXLA Common Stock J - Other D 4,4200 4.305.541 19.030 4.305.541
2020-09-03 2020-09-01 4 Aradhye Shreeram AXLA Stock Option (Right to Buy) A - Award D 4,89 22.000 22.000
2020-06-08 2020-06-05 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 9,00 6.800 6.800
2020-05-22 2020-05-20 4 Baird William D III AXLA Stock Option (Right to Buy) A - Award D 4,20 11.000 11.000
2020-05-22 2020-05-20 4 Behar Gregory AXLA Stock Option (Right to Buy) A - Award D 4,20 11.000 11.000
2020-05-22 2020-05-20 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 4,20 65.000 65.000
2020-05-22 2020-05-20 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 4,20 35.000 35.000
2020-05-22 2020-05-20 4 Hoge Stephen AXLA Stock Option (Right to Buy) A - Award D 4,20 11.000 11.000
2020-05-22 2020-05-20 4 Pisano Gary P. AXLA Stock Option (Right to Buy) A - Award D 4,20 11.000 11.000
2020-05-22 2020-05-20 4 Rondinone CRISTINA AXLA Stock Option (Right to Buy) A - Award D 4,20 11.000 11.000
2020-05-22 2020-05-20 4 Sohn Catherine A. AXLA Stock Option (Right to Buy) A - Award D 4,20 11.000 11.000
2020-05-21 2020-05-18 4 Nestle Health Science US Holdings, Inc. AXLA Common Stock P - Purchase I 4,7500 1.936.842 9.200 4.305.541
2020-05-20 2020-05-18 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock P - Purchase I 4,7500 1.900.000 9.025 2.886.023
2020-05-20 2020-05-18 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock P - Purchase I 4,7500 380.000 1.805 1.056.752
2020-05-20 2020-05-18 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock P - Purchase I 4,7500 1.520.000 7.220 4.808.780
2020-05-20 2020-05-18 4 Epstein David R AXLA Common Stock P - Purchase D 4,7500 50.000 238 118.103
2020-03-02 2020-02-28 4 Epstein David R AXLA Common Stock P - Purchase D 3,7500 2.005 8 68.103
2020-03-02 2020-02-27 4 Epstein David R AXLA Common Stock P - Purchase D 3,6500 12.800 47 66.098
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4.737.398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4.737.398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4.737.398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4.737.398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4.737.398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4.737.398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4.737.398
2020-01-31 2020-01-31 4 Chardonnet Laurent AXLA Common Stock P - Purchase D 4,9400 3.000 15 3.665
2020-01-28 2020-01-27 4 Chardonnet Laurent AXLA Common Stock P - Purchase D 4,9400 352 2 665
2020-01-28 2020-01-24 4 Chardonnet Laurent AXLA Common Stock P - Purchase D 4,9200 313 2 313
2020-01-21 2020-01-17 4 Sohn Catherine A. AXLA Common Stock P - Purchase D 4,8700 1.000 5 1.000
2020-01-03 2020-01-02 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 4,12 156.700 156.700
2019-12-20 2019-12-18 4 Chardonnet Laurent AXLA Stock Option (Right to Buy) A - Award D 3,40 72.500 72.500
2019-12-20 2019-12-18 4 Chakravarthy Manu AXLA Stock Option (Right to Buy) A - Award D 3,40 41.000 41.000
2019-12-20 2019-12-18 4 Fehlner Paul AXLA Stock Option (Right to Buy) A - Award D 3,40 18.000 18.000
2019-12-20 2019-12-18 4 Aradhye Shreeram AXLA Restricted Stock Units A - Award D 66.801 66.801
2019-12-20 2019-12-18 4 Aradhye Shreeram AXLA Stock Option (Right to Buy) A - Award D 3,40 54.500 54.500
2019-12-20 2019-12-18 4 Tramontin Tony AXLA Stock Option (Right to Buy) A - Award D 3,40 45.000 45.000
2019-12-20 2019-12-18 4 King-Jones Heidy AXLA Stock Option (Right to Buy) A - Award D 3,40 35.000 35.000
2019-12-20 2019-12-18 4 Mitchener Stephen AXLA Stock Option (Right to Buy) A - Award D 3,40 43.000 43.000
2019-12-03 2019-11-27 4 Epstein David R AXLA Common Stock P - Purchase D 3,9100 1.005 4 53.298
2019-12-03 2019-11-26 4 Epstein David R AXLA Common Stock P - Purchase D 3,5500 14.000 50 52.293
2019-12-02 2019-11-27 4 Epstein David R AXLA Common Stock P - Purchase D 3,9100 1.005 4 53.298
2019-12-02 2019-11-26 4 Epstein David R AXLA Common Stock P - Purchase D 3,5500 14.000 50 52.293
2019-08-29 3 Maltbie Shane AXLA Common Stock D 8.142
2019-08-29 3 Maltbie Shane AXLA Common Stock D 8.142
2019-08-29 3 Maltbie Shane AXLA Common Stock D 8.142
2019-08-23 2019-08-21 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 8,11 65.000 65.000
2019-08-23 2019-08-21 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 8,11 35.000 35.000
2019-08-23 2019-08-21 4 Sohn Catherine A. AXLA Stock Option (Right to Buy) A - Award D 8,11 22.000 22.000
2019-08-05 2019-08-02 4 Epstein David R AXLA Common Stock P - Purchase D 7,0400 2.849 20 38.293
2019-08-05 2019-08-01 4 Epstein David R AXLA Common Stock P - Purchase D 6,9800 4.092 29 35.444
2019-07-18 2019-07-17 4 Epstein David R AXLA Common Stock P - Purchase D 7,5500 1.000 8 31.352
2019-07-10 2019-07-10 4 Epstein David R AXLA Common Stock P - Purchase D 8,0700 1.322 11 30.352
2019-07-10 2019-07-09 4 Epstein David R AXLA Common Stock P - Purchase D 8,2400 4.200 35 29.030
2019-07-10 2019-07-08 4 Epstein David R AXLA Common Stock P - Purchase D 9,0000 274 2 24.830
2019-07-03 2019-07-03 4 Epstein David R AXLA Common Stock P - Purchase D 8,9900 56 1 19.056
2019-07-03 2019-07-02 4 Epstein David R AXLA Common Stock P - Purchase D 8,7650 3.500 31 19.000
2019-07-03 2019-07-01 4 Epstein David R AXLA Common Stock P - Purchase D 8,7350 1.000 9 15.500
2019-07-01 2019-06-28 4 Epstein David R AXLA Common Stock P - Purchase D 10,0400 5.400 54 20.000
2019-07-01 2019-06-27 4 Epstein David R AXLA Common Stock P - Purchase D 9,1500 100 1 14.600
2019-06-27 2019-06-26 4 Epstein David R AXLA Common Stock P - Purchase D 9,5700 14.500 139 14.500
2019-05-24 2019-05-22 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 14,28 11.000 11.000
2019-05-24 2019-05-22 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 13,83 60.803 60.803
2019-05-24 2019-05-22 4 BERRY DAVID A AXLA Stock Option (Right to Buy) A - Award D 14,28 11.000 11.000
2019-05-24 2019-05-22 4 Pisano Gary P. AXLA Stock Option (Right to Buy) A - Award D 14,28 11.000 11.000
2019-05-24 2019-05-22 4 Hoge Stephen AXLA Stock Option (Right to Buy) A - Award D 14,28 11.000 11.000
2019-05-24 2019-05-22 4 Rondinone CRISTINA AXLA Stock Option (Right to Buy) A - Award D 14,28 11.000 11.000
2019-05-24 2019-05-22 4 Baird William D III AXLA Stock Option (Right to Buy) A - Award D 14,28 11.000 11.000
2019-05-24 2019-05-22 4 Behar Gregory AXLA Stock Option (Right to Buy) A - Award D 14,28 11.000 11.000
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series E Preferred Stock C - Conversion I -895.255 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series E Preferred Stock C - Conversion I -89.525 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series E Preferred Stock C - Conversion I -358.102 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series C Preferred Stock C - Conversion I -151.643 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series C Preferred Stock C - Conversion I -617.914 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series C Preferred Stock C - Conversion I -222.506 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series B Preferred Stock C - Conversion I -1.005.413 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series B Preferred Stock C - Conversion I -928.074 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series B Preferred Stock C - Conversion I -386.697 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series A Preferred Stock C - Conversion I -4.153.847 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series A Preferred Stock C - Conversion I -1.384.615 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock P - Purchase I 20,0000 500.000 10.000 986.023
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 486.023 486.023
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 48.602 676.752
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 194.409 3.288.780
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 82.324 628.150
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 335.457 3.094.371
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 120.795 1.761.029
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 545.826 545.826
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 503.840 2.758.914
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 209.933 1.640.234
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 2.255.074 2.255.074
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 751.691 1.430.301
2019-05-08 3 BERRY DAVID A AXLA Common Stock D 1.520.084
2019-05-08 3 BERRY DAVID A AXLA Common Stock D 1.520.084
2019-05-08 3 BERRY DAVID A AXLA Common Stock D 1.520.084
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3.393.050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4.750.270
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista